Clinical Trials
12 trialsNCT01005368 2022-08-03
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Alliance for Clinical Trials in Oncology
Completed
NCT01139333 2016-05-18
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01150656 2016-05-18
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01245231 2016-05-18
Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01500499 2016-05-18
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01075425 2016-04-15
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Virginia Commonwealth University
Phase 1 Completed
NCT01232855 2015-10-02
Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia
Children's Oncology Group
Completed
NCT01150058 2015-05-12
Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01138332 2015-05-06
Biomarkers in Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT00899743 2015-03-06
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia
SWOG Cancer Research Network
Completed
NCT00686218 2014-08-15
Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT01016990 2014-01-10
Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
Phase 2 Unknown